Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Athersys Inc., 3201 Carnegie Ave., Cleveland, OH 44115, USA.
High-throughput target discovery requires robust disease models and the ability to rapidly survey the genome for function. In the post-genomics era, there has been a strong emphasis placed upon "gene-to-function" approaches that take advantage of the large amount of gene sequence information now available. Here, we advocate a return to "function-to-gene" approaches as a first step in target discovery (and validation), followed by hypothesis-driven research to validate new targets identified by their activity in cell-based disease models.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on